Diverse models. Precise discovery.

Test the population,
not the average.

Sanve Labs builds genetically diverse model systems to screen drug candidates across a broad range of genetic backgrounds. The most promising candidates are then validated in a genetically diverse panel of human cell lines, uncovering differences in drug response and potential risk.

These insights help sponsors prioritize candidates and inform more targeted clinical trial design, with the goal of identifying patient subgroups most likely to benefit before late-stage development.